CEL-SCI Market Cap

CEL-SCI has a market cap or net worth of $18.13 million as of July 15, 2025. Its market cap has decreased by -71.14% in one year.

Market Cap

18.13M

Enterprise Value

27.24M

1-Year Change

-71.14%

Ranking

#4950

Market Cap Chart

Since December 1, 1998, CEL-SCI's market cap has decreased from $27.40M to $18.13M, a decrease of -33.84%. That is a compound annual growth rate of -1.54%.

Market Cap History

Date	Market Cap	% Change
Jul 14, 2025	11.00M	-55.28%
Dec 31, 2024	24.60M	-81.90%
Dec 29, 2023	135.90M	32.46%
Dec 30, 2022	102.60M	-66.58%
Dec 31, 2021	307.00M	-33.78%
Dec 31, 2020	463.60M	43.22%
Dec 31, 2019	323.70M	297.18%
Dec 31, 2018	81.50M	226.00%
Dec 29, 2017	25.00M	96.85%
Dec 30, 2016	12.70M	-73.60%
Dec 31, 2015	48.10M	-9.42%
Dec 31, 2014	53.10M	80.61%
Dec 31, 2013	29.40M	-60.16%
Dec 31, 2012	73.80M	10.81%
Dec 30, 2011	66.60M	-60.45%
Dec 31, 2010	168.40M	25.11%
Dec 31, 2009	134.60M	300.60%
Dec 31, 2008	33.60M	-42.37%
Dec 31, 2007	58.30M	27.85%
Dec 29, 2006	45.60M	25.27%
Dec 30, 2005	36.40M	-15.74%
Dec 31, 2004	43.20M	-37.39%
Dec 31, 2003	69.00M	845.21%
Dec 31, 2002	7.30M	-67.12%
Dec 31, 2001	22.20M	-27.69%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	717.60B
Johnson & Johnson	377.32B
AbbVie	338.30B
Novo Nordisk	308.09B
UnitedHealth Group	272.67B
Novartis AG	237.08B
Abbott Laboratories	229.71B
AstraZeneca	222.35B

Market Cap Rankings